| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $2.2B | $1.3B |
| Cost of Revenue | $0.2B | $0.1B |
| Gross Profit | — | — |
| R&D Expense | $0.8B | $0.9B |
| SG&A Expense | — | — |
| Operating Income | $0.4B | $-0.6B |
| Net Income | $0.5B | $-0.5B |
| EPS (Basic) | $2.84 | $-3.33 |
| EPS (Diluted) | $2.62 | $-3.33 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $3.2B | $2.3B |
| Current Assets | $3.1B | $2.2B |
| Cash & Equivalents | $1.0B | $0.6B |
| Total Liabilities | $0.3B | $0.2B |
| Current Liabilities | $0.3B | $0.2B |
| Stockholders' Equity | $2.9B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $0.7B | $0.2B |
| Investing Cash Flow | $-0.2B | $-0.4B |
| Capital Expenditures | $0.0B | $0.0B |
| Financing Cash Flow | $-0.1B | $0.4B |